Biosimilar Competition and Pricing Pressure: The Economic...

added blog Health

2025-11-21 11:10:51 -

The **Acute Myeloid Leukemia (AML) segment** is currently the area of most dynamic growth and change within the **US Leukemia Therapeutics Market**. Historically, AML treatment relied heavily on intensive, toxic chemotherapy (the '7+3' regimen), which yielded poor outcomes, especially for older patients or those with relapsed/refractory disease. This scenario created a massive unmet clinical...

0 Comments 0 Shares 8 Views 0 Reviews